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Abstract Voltage-gated calcium channels are essential players in many physiological processes in
excitable cells. There are threemain subdivisions of calcium channel, defined by the pore-forming
α1 subunit, the CaV1, CaV2 and CaV3 channels. For all the subtypes of voltage-gated calcium
channel, their gating properties are key for the precise control of neurotransmitter release, muscle
contraction and cell excitability, among many other processes. For the CaV1 and CaV2 channels,
their ability to reach their required destinations in the cell membrane, their activation and the
fine tuning of their biophysical properties are all dramatically influenced by the auxiliary subunits
Annette Dolphin received her BA in Natural Sciences (Biochemistry) from the University of Oxford and her PhD from University
of London, Institute of Psychiatry. She then held postdoctoral fellowships at the College de France in Paris with Joel Bockart, and at
Yale University with Paul Greengard, before returning to UK to a staff scientist post at the National Institute for Medical Research,
London, working with Tim Bliss. She then moved to an academic position as a lecturer in the Pharmacology Department of St
George’s Hospital Medical School, London University. She was appointed Chair of the Department of Pharmacology at Royal Free
Hospital School of Medicine, London University in 1990, and moved to University College London in 1997. She is Professor of
Pharmacology in theDepartment ofNeuroscience, Physiology and Pharmacology at UCL. Shewas elected to the Academy ofMedical
Sciences in 1999, and the Royal Society in 2015. She is currently a Wellcome Trust Senior Investigator.
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society DOI: 10.1113/JP272262
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution
and reproduction in any medium, provided the original work is properly cited.
2 A. C. Dolphin J Physiol 000.0
that associate with them. Furthermore, there are many diseases, both genetic and acquired,
involving voltage-gated calcium channels. This review will provide a general introduction and
then concentrate particularly on the role of auxiliary α2δ subunits in both physiological and
pathological processes involving calcium channels, and as a therapeutic target.
(Received 31 March 2016; accepted after revision 9 May 2016; first published online 8 June 2016)
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Abstract figure legend Diagram of a presynaptic terminal showing a CaV2 calcium channel and associated GPCR.
Abbreviations AID, α-interaction domain; AP-1, adaptor protein complex-1; BBS, bungarotoxin binding site; BTX,
α-bungarotoxin; DRG, dorsal root ganglion; EM, electron microscopy; ER, endoplasmic reticulum; GK, guanylate
kinase; GPCR, G-protein coupled receptor; GPI, glycosyl-phosphatidyl inositol; HIV, human immunodeficiency virus;
MIDAS, metal ion-dependent adhesion site; PMCA, plasmamembrane Ca2+-ATPase; RyR, ryanodine receptor; SERCA,
sarcoplasmic and endoplasmic reticulum Ca2+ ATPase; SH3, src homology-3; SNP, single nucleotide polymorphism;
VWA, Von Willebrand Factor-A domain.
Introduction
Excitable cells contain functional voltage-gated ion
channels, including calcium channels. Neurons and
muscle cells are conventionally excitable, but many
other cell types show oscillatory changes in voltage,
dependent on the interplay between voltage-gated and
calcium-dependent channels (for example see Hu et al.
2012). Free intracellular Ca2+ is maintained at 10–100 nM
in the cytoplasm, a low level relative to the extracellular
milieu. Voltage-gated calcium channels then react to
membrane depolarization by opening, and thus allowing
Ca2+ to move down its electrochemical gradient.
Ca2+ entry, particularly but not exclusively through
voltage-gated calcium channels, provides an elevation of
intracellular calcium ion concentration, to drive many
processes. These include hormone secretion, neuro-
transmitter release, calcium-dependent transcription of a
variety of genes, and also spontaneous pacemaker activity
in some neurons, muscles and secretory cells (Mangoni
et al. 2003; Guzman et al. 2009; Putzier et al. 2009; Hu
et al. 2012; Striessnig et al. 2015). The present review
concentrates particularly on the roles of the accessory α2δ
subunits. For more comprehensive coverage of calcium
channel function, the reader is directed to other recent
reviews (Striessnig et al. 2014; Zamponi et al. 2015;
Zamponi, 2016).
Voltage-gated calcium channel subunits
Functional voltage-gated calcium channels are composed
of pore-forming α1 subunit proteins, encoded by the
CACNA1x genes (for review see Catterall et al. 2003), of
which there are 10 isoforms in themammalian genome. In
the case of the CaV1.1–CaV1.4 channels (known as L-type
channels), these are encoded by CACNA1S, -C, -D and -F,
respectively, and also known asα1S,α1C,α1D andα1F. The
CaV2.1–CaV2.3 channels (termed P/Q -, N-and R-type
from physiological experiments: Nowycky et al. 1985;
Mintz et al. 1992; Piedras-Renterı´a & Tsien, 1998) are
encoded by CACNA1A, -B and -E, respectively, and also
known as α1A, α1B and α1E. The T-type CaV3 channels
(encoded by CACNA1G, -H and -I) are also termed α1G,
α1H and α1I (Cribbs et al. 1998; Perez-Reyes et al. 1998).
They are much more similar to each other than to the
CaV1 and CaV2 channels (Fig. 1).
Although the α1 subunits dictate the principal
biophysical and pharmacological properties of these
channels, their expression is enhanced and their properties
aremodified by the twomain auxiliary (or accessory) sub-
units (Tanabe et al. 1987; Mikami et al. 1989; Mori et al.
1991; Varadi et al. 1991). The α2δ and β subunits also play
important roles in channel folding and their subsequent
transport to the cell surface, and into particular domains
of polarized cells such as neurons. These processes are
together known as trafficking, and involve multiple steps.
Both the CaV1 and CaV2 classes of channels are able to
form a heteromeric complex, co-assembling with one of
four β subunits (encoded by CACNB1—4; Fig. 2A and B),
and one of fourα2δ subunits (encoded byCACNA2D1—4;
Fig. 2A andC). For the CaV3 channels, the α1 subunits can
form functional channels alone, but may also associate
with other proteins.
All of the α1, β and α2δ subunits form a large
number of variants as a consequence of alternative splicing
events. This opens the potential for a huge diversity of
properties and function. A γ subunit also forms part
of the skeletal muscle calcium channel complex, which
comprises CaV1.1, β1a, γ1 and α2δ-1(Jay et al. 1990).
However, although multiple other γ subunits have been
cloned (Letts et al. 1998; Moss et al. 2002; Tomita et al.
2003), no γ subunits have been shown to form an integral
part of cardiac (Walsh et al. 2009) or neuronal (Moss
et al. 2002; Mu¨ller et al. 2010) calcium channels. In
contrast, they have well-defined roles as transmembrane
AMPA-glutamate receptor modifying proteins (Tomita
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et al. 2003). Furthermore, for some CaV1 and CaV2
calcium channels, the tight binding of calmodulin to
the so-called ‘IQ’ domain in their C-terminal tail allows
calmodulin to be considered as a quasi-subunit (Mori et al.
2008; Kim et al. 2010; Ben-Johny et al. 2013).
Voltage-gated calcium channel localization
CaV1.1 is the only isoform present in mammalian
skeletal muscle t-tubules, and shows very low expression
elsewhere, including brain (Bannister & Beam, 2013).
CaV1.2 is the main isoform in ventricular cardiac muscle,
and is also present in smooth muscle cells, secretory tissue
and the nervous system (Striessnig et al. 2014). CaV1.3 has
a more limited localization than CaV1.2, playing a major
role in sinoatrial node tissue, and in the auditory system
(Platzer et al. 2000; Mangoni et al. 2003; Baig et al. 2011),
although it is also present in brain. It is also present in
some endocrine tissues, including aldosterone-secreting
cells of the adrenal gland, where somatic mutations give
rise to resistant hypertension (Azizan et al. 2013; Scholl
et al. 2013). CaV1.4 shows very restricted distribution,
particularly in the visual system (Mansergh et al. 2005).
The CaV2.x channels show a primarily neuronal
distribution and are involved in fast neurotransmitter
release (Takahashi&Momiyama, 1993;Wu et al.1999;Cao
& Tsien, 2010). CaV2.1 channels are present throughout
the brain, and are particularly prevalent in cerebellum
(Ophoff et al. 1996), where theymake up the predominant
calcium current in Purkinje neurons (Mintz et al. 1992;
Westenbroek et al. 1995). They are involved in neuro-
transmission inmostmaturemammalian central synapses
(Westenbroek et al. 1995; Iwasaki et al. 2000, 2005;
Nakamura et al. 2015). CaV2.2 is distributed throughout
the central (Westenbroek et al. 1992) and peripheral
nervous systems (Lipscombe et al. 1988; Boland et al.
1994; Wheeler et al. 1994). It is particularly important
for neurotransmission early in mammalian development,
although it co-exists with CaV2.1 inmost mature synapses
(Iwasaki et al. 2000). CaV2.2 also plays a dominant role
in the mature peripheral nervous system (Chaplan et al.
1994; Bowersox et al. 1996). CaV2.3, although originally
described as being low voltage activated (Soong et al.
1993), is thought to correspond to residual R-type calcium
current (Zhang et al. 1993; Tottene et al. 2000; Wilson
et al. 2000). It is present in many brain regions and is
found both pre- and postsynaptically in neurons (Parajuli
et al. 2012). CaV2.3 has been found to be involved in
spontaneous release of glutamate (Ermolyuk et al. 2013),
although theCaV2.3blocker SNX-482 alsoblocks someK+
channels, making dissection of its physiological functions
more difficult (Kimm & Bean, 2014).
The CaV3 channels are extensively distributed in
neurons and other excitable cells (Cribbs et al. 1998;
Perez-Reyes, 1998; Perez-Reyes et al. 2009). For example,
they are prevalent in the thalamus (Perez-Reyes, 2003),
and alsohave important roles inprimary afferent pathways
(Francois et al. 2015; Gadotti et al. 2015; for recent review
see Zamponi et al. 2015). They have important roles in
neuronal and cardiac excitability and in cardiac andneuro-
nal pacemaker activity (Perez-Reyes, 2003; Guzman et al.
2009; Putzier et al. 2009). In some synapses they also have
a presynaptic function in transmitter release (Huang et al.
2011; Carbone et al. 2014).
Association of α1 subunits with auxiliary subunits
Biochemical isolation of calcium channels has indicated
that native L-, N - and P/Q -type channels in muscle and
brain are all associated with β and α2δ subunits (Tanabe
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Figure 1. Calcium channel α1 subunit homology
The relationship between the 10 mammalian voltage-gated
calcium channel α1 subunits, and their gene names (black)
and protein nomenclature (red and blue). The calcium
channels were historically first divided into high
voltage-activated (HVA) and low voltage-activated (LVA).
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et al. 1987; Witcher et al. 1993; Liu et al. 1996). However,
it has been noted that the association of the α2δ subunit
with the channel complex is more easily dissociated by the
detergents used during purification than the interaction
of the β subunit (Jay et al. 1991; Gee et al. 1996; Mu¨ller
et al. 2010). It is also possible that not all native calcium
channel complexes contain an α2δ subunit. By contrast
the association between the α1 and β subunits is quite
robust, and shows a high affinity for interaction with the
intracellular loop between domains I and II of CaV1 and
CaV2 channels (Pragnell et al. 1994; Canti et al. 2001; Van
Petegem et al. 2004). Despite this difference, both the β
and α2δ subunits increase the expression and function of
these channels, as described below.
Structural information on voltage-gated calcium
channels
There is detailed structural information concerning the
cytoplasmicβ subunits. Initially amodelling study showed
that β subunits contained a core SH3 and guanylate
kinase-like (GK) domain (Hanlon et al. 1999; Fig. 2B).
This was confirmed in X-ray crystallographic studies of
the SH3-GK core domains of three calcium channel β sub-
units, in association with an interacting peptide derived
from the I-II linker (Chen et al. 2004; Opatowsky et al.
2004; Van Petegem et al. 2004). From these and other
studies, theGKdomain is seen to bind to theα-interaction
domain (AID) which is in the proximal part of the I-II
linker (Fig. 2A). The β subunit is thought to promote
the formation of an α-helix, in the AID motif, extending
back to the end of S6 in domain I (Opatowsky et al.
2004; for reviews see Richards et al. 2004; Buraei & Yang,
2010). This is likely to promote folding to form mature
channels.
More recently, very valuable crystallographic
information pertaining to the α1 subunit structure
has come from studies of the bacterial single domain
sodium channel NaVAb, whose structure was solved
by X-ray crystallography (Payandeh et al. 2011). Sub-
sequently, key residues in the pore of this channel were
mutated to render the channel Ca2+ permeable (Tang
HOOK
SH3
VWA
GK
ω-site
RRR
Signal sequence
α2δ-1 α2
α2δ
α2δ-4
α2δ-1
α2δ-2
α2δ-3
Cachd1
Out
In
I II IVIIII
S1 S2 S3 S4 S5 S6 S5 S6 S5 S6 S5 S6S1 S2 S3 S4 S1 S2 S3 S4 S1 S2 S3 S4
α2
δ
β
β
δ
B
C
D
A
Figure 2. Domains in β and α2δ subunits and their interaction with the α1 subunit
A, topology of the calcium channel complex. B, known domains in β subunits. C, known domains in α2δ subunits.
D, approximate phylogenetic tree generated for mouse α2δ subunits using http://www.phylogeny.fr/. The VWA
and Cache containing protein Cachd1 is included for comparison. The sequences AAI15872.1, AAH56389.1,
EDL24740.1, AAI41092.1 and NP_932154.1 were used.
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et al. 2014); this structure was able to provide detailed
information about the Ca2+ permeation pathway. There
are also structures of calmodulin interacting with the
proximal C-terminus of CaV1.2 (Kim et al. 2008, 2010),
revealing the nature of this interaction and shedding light
on the mechanism of Ca2+-dependent inactivation.
The initial low resolution single particle electronmicro-
graphic (EM) structures of the L-type calcium channel
complex, also called the dihydropyridine receptor, from
skeletal muscle (Serysheva et al. 2002; Wolf et al. 2003;
Wang et al. 2004; Hu et al. 2015) and cardiac muscle
(Walsh et al. 2009), showed an asymmetric structure, with
a density identified asα2δ extending out from the complex.
More recently a high resolution cryo-EM structure of the
CaV1.1 calcium channel complex purified from skeletal
muscle has now provided us with much greater detail, at
near atomic resolution, particularly regarding the trans-
membrane organization and pore of the α1 subunit, and
the orientation of the α2δ subunit domains (Wu et al.
2015). It has shown a clockwise arrangement of the α1
subunit domains, and identified that there are multiple
interactions of α2δ-1 subunit with the extracellular loops
of domains I-III of the α1S subunit.
Modulation of calcium channel function by second
messengers and G proteins
There is insufficient space in this review to cover the
enormous amount of information on multiple second
messenger effects on calcium channel function. Three key
areas that can be highlighted are firstly: Ca2+-dependent
inactivation and facilitation of CaV2.1, CaV1.2 and CaV1.3
channels, by interaction with calmodulin associated with
the C-terminal tail of the α1 subunit (Dick et al.
2008; Minor & Findeisen, 2010; Ben-Johny et al. 2013).
Secondly, there is an important phosphorylation process
that is responsible for β-adrenergic stimulation of cardiac
calcium currents (Reuter, 1987; Fuller et al. 2010). The
mechanism involves enhancement of CaV1.2 currents
by cyclic AMP-dependent protein kinase, which results
from phosphorylation-induced relief of auto-inhibition
by a peptide cleaved from the channel C-terminus (Fuller
et al. 2010; Fu et al. 2013). Thirdly, there is a ubiquitous
G-protein coupled receptor (GPCR)-mediated inhibition
of the CaV2 class of channels mediated by Gβγ (Dolphin,
2003; Zamponi & Currie, 2013).
Regarding the interplay between second messenger
modulation and auxiliary subunits, initial studies
identified that Gβγ bound to a site on the I-II linker
of CaV2 channels that overlapped with the CaVβ sub-
unit (Zamponi et al. 1997), opening the possibility that
they compete for this binding site. We then identified
that in the absence of a CaVβ subunit, Gβγ-mediated
inhibition is still present, but it is not voltage dependent,
meaning that it cannot be removed by preceding
depolarization. Therefore, the presence of the CaVβ sub-
unit is required for Gβγ-mediated G-protein modulation
to show voltage-dependent properties (Meir et al. 2000;
Zhang et al. 2008), and a simple competition for binding
is not responsible forGβγ-mediated inhibition. Further to
this, we identified key residues within the N-terminus of
CaV2 channels that are essential for G-proteinmodulation
(Page et al. 1998; Canti et al. 1999; Leroy et al. 2005), and
this work was extended by others (Agler et al. 2005).
Interplay between the action of β and α2δ subunits
in calcium channel function
For both CaV1 and CaV2 channels, the CaVβ subunits are
extremely important for expression of functional channels
in several heterologous expression systems (Varadi et al.
1991; Pragnell et al. 1994; Jones et al. 1998; Leroy et al.
2005). Interaction of the α1 subunit with a β subunit has
a number of consequences. By binding via their guanylate
kinase domain (Fig. 2B) to the intracellular AID motif
on the α1 subunits (Pragnell et al. 1994; Fig. 2A), they
increase folding of the channels and protect the channels
fromendoplasmic reticulum (ER)-associated proteasomal
degradation (Altier et al. 2011; Waithe et al. 2011); thus
they allow more channels to reach the plasma membrane
(Fig. 3A). However, it is difficult to determine whether
β subunits are absolutely essential for α1 subunits to
reach the cell surface. This suffers from the problem that
several expression systems, in particular Xenopus oocytes,
express native β subunits (Canti et al. 2001). The α2δ sub-
units produce an additional increase in current density,
described inmoredetail below (Fig. 3B).However, because
a number of expression systems, including Xenopus
oocytes, HEK-293 and the tsA-201 cells derived from
them, also contain some endogenous α2δ-1 (Singer-Lahat
et al. 1992; Dolphin et al. 1999; Kadurin et al. 2012a), this
also complicates assessment of their role. Nevertheless,
both α2δ and β subunits increase the expression at the
plasmamembrane of CaV1 and CaV2 channels, and where
it has been investigated, some evidence suggests that α2δ
subunits are poorly effective unless the CaVβ subunits are
also expressed (Cassidy et al. 2014; Fig. 4).
Isoforms and topology of α2δ
All the α2δ proteins have a similar structure (for reviews
see Felix, 1999; Davies et al. 2007; Dolphin, 2012; Fig. 2C
and D). The N-terminus has a signal sequence directing
the nascent polypeptide into the lumen of the ER, such
that it becomes extracellular, once transported to the
plasma membrane (Fig. 2C). Several domains can be
identified in the sequence of α2δ proteins, including a Von
WillebrandFactor-A (VWA)domain (Whittaker&Hynes,
2002; Fig. 2C). These domains, as well as being present
in von Willebrand factor itself, are generally involved in
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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extracellular protein–protein interactions, dependent on
divalent cations, particularly by integrins and extracellular
matrix proteins. A keymotif in VWA domains is the metal
ion-dependent adhesion site (MIDAS), which involves
coordination of the divalent cation by a ring of up to
five polar or charged residues (Whittaker & Hynes, 2002).
If the MIDAS site is ‘perfect’, with the full complement
of five residues, it is highly likely to be involved in
such protein–protein interactions (Whittaker & Hynes,
2002), and this is the case in α2δ-1 and α2δ-2 (Canti
et al. 2005), whereas α2δ-3 and α2δ-4 have one missing
polar residue in the MIDAS motif. There is also a
region in the α2δ subunits containing so-called Cache
domains,whichhavehomology tobacterial chemosensory
domains (Anantharaman & Aravind, 2000; Dolphin,
2012). The recent EM structure also identified a Cache
domain, N-terminal to the VWA domain (Wu et al.
2015). There are other identified genes with predicted
similarity to α2δ subunits, such as CACHD1 (Whittaker
& Hynes, 2002) (Fig. 2D), whose functions remain to be
determined.
TheC-termini of allα2δ subunits all have a hydrophobic
region first identified to be a transmembrane domain
(Ellis et al. 1988; Jay et al. 1991). This led to the α2δ
proteins being described as single pass type I (C-terminal
cytoplasmic) transmembrane proteins. From prediction
progams we found that at least two of the α2δ subunits
(α2δ-3 and α2δ-4) are predicted with high likelihood to
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Figure 3. Examples of effects of auxiliary subunits on CaV2.2 calcium channel currents
A, CaV2.2 calcium currents: effect of β subunits. Example of peak CaV2.2 current at 0 mV in the absence of β (blue)
and presence of β1b (black). B, CaV2.2 calcium currents: effect of α2δ subunits. Example of peak CaV2.2/β1b
current at 0 mV in the absence of α2δ (red) and presence of α2δ-3 (black). Scale bars apply to both A and B. Charge
carrier 1 mM Ba2+, expression in tsA-201 cells, as in a previous study (Leroy et al. 2005). C, effect of different α2δ
subunits on inactivation. Examples of normalized peak current for CaV2.2–β1b (black), CaV2.2–β1b–α2δ-2 (blue)
and CaV2.2–β1b–α2δ-1 (red), over a 2.5 s timescale. Expression in Xenopus oocytes, as in a previous study (Canti
et al. 2005).
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Figure 4. CaV2.2 cell surface expression: effects of
β1b and α2δ-1
Cell surface expression of bungarotoxin binding site (BBS)
tagged CaV2.2 labelled with α-bungarotoxin (BTX)
coupled to AF488 dye (green). Top panel: examples of N2a
cells transfected with CaV2.2–β1b–α2δ-1 (left),
CaV2.2–β1b (middle) and CaV2.2–α2δ-1 (right). Scale bar
20 μm. Bottom panel: mean (± SEM) data for cell surface
expression of CaV2.2, for cells expressing
CaV2.2–β1b–α2δ-1 (black bar), CaV2.2–β1b (red bar) and
CaV2.2–α2δ-1 (green bar) or CaV2.2 alone (blue bar). Data
are taken from a recent study (Cassidy et al. 2014).
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be glycosyl-phosphatidyl inositol (GPI)-anchored, partly
because the C-terminal hydrophobic domain is very short
and present at the extreme C-terminus, as well as the pre-
sence of a predicted GPI-anchor ω-site (Pierleoni et al.
2008; Davies et al. 2010). We have provided evidence for
this post-translational modification for α2δ-1, α2δ-2 and
α2δ-3 (Davies et al. 2010; Alvarez-Laviada et al. 2014). The
genes for all the α2δ subunits encode a single precursor
protein, which is post-translationally proteolytically
processed into two polypeptides (Jay et al. 1991). The α2
and δ polypeptides remain disulfide-bonded together. The
cysteines residues involved in this disulfide bonding have
been determined for α2δ-1 (Calderon-Rivera et al. 2012).
Wehave recently been studying the relevanceof proteolytic
processing into α2 and δ to the physiological function
of α2δ (Kadurin et al. 2012b, and authors’ unpublished
data).
Effect of α2δ subunits on calcium channels reaching
the plasma membrane
In general, the α2δ subunits have been found to increase
the expression (either functional expression or amount
of protein on the plasma membrane) of several different
CaV1 or CaV2 combinations with β subunits (Shistik et al.
1995; Gurnett et al. 1996; Felix et al. 1997; Wakamori
et al. 1999; Gao et al. 2000; Yasuda et al. 2004; Canti
et al. 2005; Davies et al. 2010). For example, for the
CaV2.1–β4 combination, calcium currents were increased
3-fold by α2δ-2. This set of calcium channel subunits
is found in cerebellar Purkinje cells, where α2δ-2 is
strongly represented (Barclay et al. 2001; Brodbeck et al.
2002). However, α2δ-2 did not alter the single channel
conductance, suggesting strongly that the large increase in
whole cell current is solely due to an increase in thenumber
of functional channels at the cell surface (Barclay et al.
2001; Brodbeck et al. 2002). However, the term ‘increased
number of functional channels’ can indicate increased
amount of channel protein in the plasma membrane
and/or an increased proportion of the channels already in
the plasma membrane able to respond to depolarization.
There is strong evidence that the cell surface expression
of CaV1 and CaV2 α1 subunits is increased by α2δ sub-
units (Fig. 4), although the mechanism(s) underlying this
increase this are still being unravelled (Tran-Van-Minh &
Dolphin, 2010; Cassidy et al. 2014).
The situation for CaV2.3 channels is less clear. It
has been reported that CaV2.3 produces relatively large
currents when expressed alone in Xenopus oocytes (Soong
et al. 1993; Schneider et al. 1994; Qin et al. 1998), and
α2δ-1 subunits did not increase CaV2.3 currents in this
expression system (Qin et al. 1998). Furthermore, in
HEK-293 cells α2δ-1 produced a 2-fold elevation of the
maximum conductance for CaV2.3 alone, although it gave
no additional increase beyond that of β subunits (Jones
et al. 1998). Thus it is possible that CaV2.3 may be less
affectedbyα2δ subunits, but thiswill require confirmation.
Increased trafficking of the calcium channels by these
α2δ subunits is highly likely not to be their onlymechanism
of action. For example, liposomes containing skeletal
muscle calcium channel protein exhibited greater calcium
flux in the presence of α2δ subunits than in their absence
(Gutierrez et al. 1991). Furthermore, the effect of α2δ-1
on CaV2.2 channel density in the plasmamembrane when
expressed in N2a cells was at the most 2-fold (Cassidy
et al. 2014), whereas there was an approximately 10-fold
increase in CaV2.2 calcium currents in the presence of
α2δ-1 (Hoppa et al. 2012). It has been suggested that
α2δ-1 reduced the apparent turnover of CaV2.2, in studies
using radiolabelled conotoxin (Bernstein & Jones, 2007),
although Cassidy et al. (2014) did not find that α2δ-1
reduced CaV2.2 endocytosis from the plasma membrane
in N2a cells.
TheperfectMIDASmotif present in theVWAdomainof
α2δ-1 andα2δ-2 subunits is required for increasing calcium
currents (Canti et al. 2005; Hoppa et al. 2012), and also
for cell surface expression of CaV2.2 (Cassidy et al. 2014).
Mutation of the MIDASmotif also reduced the trafficking
of the α2δ subunits themselves, when expressed alone
(Canti et al. 2005; Cassidy et al. 2014). This mutation also
abolished the capacity of both α2δ-1 (Hoppa et al. 2012)
and α2δ-2 (Canti et al. 2005) subunits to increase calcium
currents in several expression systems.However,α2δ-3 and
α2δ-4 do not contain perfect MIDAS motifs (Whittaker &
Hynes, 2002), and may therefore play a smaller trafficking
role, despite increasing calcium currents (Davies et al.
2010), by what must be an additional mechanism.
In an early study, it was found that the α2 sub-
unit of α2δ-1 binds to of CaV1.1 domain III (Gurnett
et al. 1997). However, the recent structural study shows
interaction of α2δ-1 with several extracellular loops in
domains I–III of CaV1.1 (Wu et al. 2015). The α2δ-1
MIDAS motif was found to be located immediately
above the linker between the first two transmembrane
segments in voltage-sensingdomain I (Wu et al.2015).The
limited structural evidence for other calciumchannels also
suggests extensive extracellular contact between CaV1.2
and α2δ-1 (Walsh et al. 2009).
The CaV3 calcium channels produce large currents in
the absence of co-expressed accessory β or α2δ subunits,
and therefore these proteins are not obligate auxiliary sub-
units for CaV3 channels. Nevertheless, both α2δ-1 and
α2δ-2 were found to increase CaV3.1 currents and cell
surface expression almost 2-fold (Dolphin et al. 1999;
Gao et al. 2000; Dubel et al. 2004); thus these channels
may have the capacity to associate with α2δ subunits.
In contrast, other studies found that α2δ-1 and α2δ-3
produced little change, whereas α2δ-2 had a larger effect
onCaV3.1 current density (Klugbauer et al. 1999; Lacinova
et al. 1999; Hobom et al. 2000).
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Trafficking of calcium channels to specific membrane
domains
The auxiliary α2δ and β subunits play major roles in
the trafficking of CaV1 and CaV2 channels not only to
the cell surface, but also to specific domains of polarized
cells, including muscle cells and neurons (Dolphin, 2012;
D’Arco et al. 2015). We have postulated that the α2δ sub-
units are highly likely to interact with proteins involved
in trafficking of membrane protein cargoes (Davies et al.
2006; Hendrich et al. 2008; Tran-Van-Minh & Dolphin,
2010). We have found that the α2δ subunits themselves
purify with cholesterol-rich lipid raft domains, and
this may influence localization of the calcium channel
complexes in plasma membrane microdomains (Davies
et al. 2006, 2010; Kadurin et al. 2012a). Interestingly,
we have also found that a truncated α2δ subunit, from
which we have removed the C-terminal GPI-anchor
motif, is mainly secreted, but nevertheless exhibits some
extrinsic plasma membrane association, via interactions
that remain to be determined (Kadurin et al. 2012a).
In recent work, we have found that the adaptor protein
complex-1 (AP-1) is important for trafficking of CaV2.2
from the trans-Golgi network to the plasma membrane,
via an alternatively spliced exon 37 in the proximal
C-terminus. The splice variant of CaV2.2 containing
exon 37a supports larger currents compared to that
containing exon 37b (Castiglioni et al. 2006), and is
selectively expressed in nociceptors (Bell et al. 2004).
Our work revealed that AP-1 binding motifs, Yxx and
[DE]xxxL[LI], present only in exon 37a, increase the intra-
cellular trafficking of exon 37a-containing CaV2.2, both to
the somatic plasmamembrane and into the axons of dorsal
root ganglion (DRG) neurons. The ability of exon37a
to increase CaV2.2 currents and cell surface density are
lost in the absence of α2δ subunits, suggesting that this
auxiliary subunit promotes a particular step in the forward
trafficking process (Macabuag & Dolphin, 2015).
Influence of α2δ subunits on biophysical properties
of calcium channels
The α2δ subunits influence the voltage-dependent and
kinetic properties of the calcium currents; in particular
they consistently increase the inactivation rate, although
to different extents. The effects of α2δ subunits may also
depend on the presence of a particular β subunit.
Activation. In the case of CaV1.2, it was found that α2δ-1
subunits exerted little effect on the activation voltage
dependence (Singer et al. 1991; Welling et al. 1993; Shistik
et al. 1995; Bangalore et al. 1996; Shirokov et al. 1998).
However, in other studies a hyperpolarizationof activation
was reported (Felix et al. 1997), and this was also observed
from conductance-voltage measurements (Platano et al.
2000). For CaV2.1, co-expressed with β4 in mammalian
cells, α2δ-2 did not affect the voltage dependence of
activation (Brodbeck et al. 2002). For CaV2.2 co-expressed
with β1b, α2δ-1 increased the activation rate of currents,
but had less effect on the voltage dependence of activation
(Wakamori et al. 1999). Contrasting results were found
for CaV2.3, which shows a greater capacity than CaV1.2 to
produce currents in the absence of the auxiliary subunits
(Stephens et al. 1997; Qin et al. 1998). For CaV2.3, α2δ-1
was found to depolarize the activation, in the presence of
either β1b or β2a, or in the absence of any β subunits
(Qin et al. 1998). In contrast, in another study α2δ-1 had
no effect on the activation voltage dependence for CaV2.3
(Jones et al. 1998).
Inactivation. In some studies, it was found that the α2δ
subunits hyperpolarized the steady-state inactivation for
several different calcium channel isoforms (Singer et al.
1991; Felix et al. 1997; Wakamori et al. 1999; Hobom
et al. 2000; Canti et al. 2005; Hendrich et al. 2008; Davies
et al. 2010), and in α2δ-1 knockout mice there was a clear
depolarization of the steady-state inactivation curve for
cardiac calcium channel currents (Fuller-Bicer et al. 2009).
However, forCaV2.3 it was found that, whereasβ1b caused
a hyperpolarization of the steady-state inactivation, α2δ-1
had no effect on this, either with or without a β subunit
(Qin et al. 1998). The α2δ subunits also increased the rate
of inactivation to varying extents, with the greatest effect
being observed for α2δ-1 (Fig. 3C; for review see Canti
et al. 2003).
Thus, although the α2δ subunits affect the kinetics
and voltage-dependent properties of the different calcium
channel isoforms, there is no clear consensus for the
different α1 and α2δ isoform combinations. One origin
of this complexity may be that there are also usually
more mature channels in the plasma membrane in the
presence of α2δ subunits. Such a diversity of effects,
although they may appear subtle when measured in iso-
lation, can have important consequences in terms of
calcium-and voltage-dependent events in cells, including
action potential shape (Hoppa et al. 2012, 2014), and the
firing properties of neurons (Margas et al. 2016).
Splice variants of α2δ subunits
The main α2δ-1 subunit splice variant present in rat brain
is different from that seen in skeletal muscle (Kim et al.
1992). Sequence alignments identified alternative splicing
in three regions, called A, B and C (Angelotti & Hofmann,
1996). Our recent study (Lana et al. 2014) indicates that
regions A and B are in separate exons, with region A in
rat being encoded by exon 18a and region B representing
an alternative 3′ splice acceptor site (start site) of exon 19.
Region C is also a cassette exon. The main splice variant
in rat skeletal muscle is +A +B C, whereas α2δ-1 (A
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+ B + C) is the principal brain splice variant (Angelotti &
Hofmann, 1996; Lana et al. 2014).We have recently shown
that it is also themain splice variant inDRGneurons (Lana
et al. 2014). However, we also identified a novel minor
splice variant (α2δ-1A + BC) in these neurons (Lana
et al. 2014). Alternative splicing of other α2δ subunits has
been described in other studies (Barclay & Rees, 2000; Qin
et al. 2002).
Distribution of α2δ subunits in the peripheral
and central nervous systems
The α2δ-1, α2δ-2 and α2δ-3 subunits are widely expressed
in both the peripheral and central nervous system, as
documented in a comprehensive in situ hybridization
study (Cole et al. 2005). α2δ-1 is present in many neuro-
nal cell types (Cole et al. 2005), including DRG neurons
(Newton et al. 2001; Bauer et al. 2009). The α2δ-1 protein
is mainly situated in presynaptic terminals, as well as, to
smaller extent, in neuronal somata, and also in dendrites
(Taylor & Garrido, 2008; Bauer et al. 2009).
The α2δ-1 transcript is expressed preferentially in
excitatory compared to inhibitory neurons (Cole et al.
2005). In contrast, α2δ-2 expression was found to
be lower than α2δ-1 in most brain regions, with
restricted areas showing significant expression, such as
the cerebellum (Cole et al. 2005). The distribution of
α2δ-2 partially correlates with expression in GABAergic
neurons, including cerebellar Purkinje neurons (Barclay
et al. 2001; Cole et al. 2005). The α2δ-3 transcript is
present throughout the brain, and is particularly pre-
valent in the caudate-putamen (Cole et al. 2005). It is
also present in the auditory system (Pirone et al. 2014)
and in the retina (Perez de Sevilla et al. 2015). In contrast,
α2δ-4 protein is found in certain endocrine tissues, and is
expressed at a low level in the brain (Qin et al. 2002). It
also plays a key role in the retina (De Sevilla Muller et al.
2013).
Role of α2δ-1 in neuropathic pain
Neuropathic pain is chronic pain resulting from nerve
damage, whichmay have a number of different underlying
causes. Neuropathic pain can be a result of trauma, either
directly damaging or impinging on axons. Trigeminal
neuralgia, which involves severe facial and jaw pain,
is often caused by trapping or pressure on sensory
nerves. Cancer-induced neuropathic pain can be also
result from direct damage to sensory nerves, or activation
of nociceptors as a result of mediators secreted from
tumours or in the inflammatory response (Schmidt et al.
2010). Neuropathic pain can also commonly be caused
by direct damage to nerves by toxins and drugs. This
would include diabetic neuropathy, due to axon damage
as a direct result of chronic elevated plasma glucose
concentration, and neuropathy caused by cancer chemo-
therapeutic drugs, for example platinum-based drugs
such as cisplatin, microtubule-disrupting taxanes, such
as paclitaxel, and vinca alkaloids including vincristine.
Some older anti-human immunodeficiency virus (HIV)
drugs, such as 2′,3′-dideoxycytidine, can also result in
nerve damage and neuropathic pain (Joseph et al. 2004).
Viral infection ofDRGs can also cause neuralgia, including
chronic post-herpetic neuralgia (following shingles), or
HIV-induced neuropathic pain, which can be mimicked
by injection of the viral coat protein HIV gp-120 (Wallace
et al. 2007; Schutz & Robinson-Papp, 2013). Thus both
HIV infection and some of the treatments used may
initiate neuropathic damage.
Sensory nerve injury results in a change in transcription
in those damaged neurons of many genes, which may be
either up- or down-regulated, often many-fold (Newton
et al. 2001; Wang et al. 2002; Xiao et al. 2002; Dawes et al.
2014). The mechanism of this effect has been investigated
for the chemotherapeutic agent paclitaxel andmay involve
injury-induced modulation of Ca2+ entry and neuro-
nal calcium sensor-1 degradation (Boehmerle et al. 2006,
2007).
Among the large number of genes whose expression is
altered, there is a consistent elevation of α2δ-1 mRNA,
shown by in situ hybridization (Newton et al. 2001),
quantitative PCR (Bauer et al. 2009), microarray analysis
(Wang et al. 2002; Xiao et al. 2002) and RNAseq (Perkins
et al. 2014). There is an equivalent increase in α2δ-1
protein in DRGs and in the dorsal horn of the spinal
cord, shown by immunoblotting (Luo et al. 2001) and
immunohistochemistry (Bauer et al. 2009). The increase
in α2δ-1 appears to occur in every damaged DRG neuron
(Bauer et al. 2009; Patel et al. 2013). In contrast, the levels
of CaV2.2 mRNA and protein are not altered in these
models (Wang et al. 2002; Li et al. 2006), although a
change in splicing of exon 37 has been documented (Altier
et al. 2007). This leads to the hypothesis that elevated
α2δ-1 results in increased CaV2.2 trafficking to terminals
or localization to active zones, thus affecting presynaptic
function. Nevertheless, α2δ-1 may also have other roles,
for example in neuronal sprouting.
Transgenic mice that overexpress α2δ-1 exhibit a base-
line phenotype of allodynia and hyperalgesia (Li et al.
2006), suggesting that the α2δ-1 level in DRG neurons is
important for determining the neuropathic response. In
agreement with these results, we have shown that in α2δ-1
knockout mice (Fuller-Bicer et al. 2009), there is a marked
reduction in baseline responses to mechanical and cold
stimulation, and a very retarded hyperalgesic response to
sciatic nerve injury, in comparison to wild-type littermate
mice (Patel et al. 2013). In agreement with this we found
that DRGs from α2δ-1 knockout mice showed strongly
reduced ability to fire multiple action potentials (Margas
et al. 2016).
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We have also recently shown that heterologous
over-expression of α2δ-1 in cultured DRG neurons
(to mimic in vitro the neuropathic state) leads to
increased calcium currents and prolonged cytoplasmic
Ca2+ responses resulting from membrane depolarization
(Fig. 5A). These prolongedCa2+ transients, once initiated,
are not dependent on extracellular Ca2+ but are buffered
by mitochondria. Thus, by controlling CaV2.2 channel
density in the plasma membrane, possibly at sites where
mitochondria and ER are also closely apposed, the α2δ-1
subunit has a large effect on depolarization-induced intra-
cellular Ca2+ signalling in DRG neurons (D’Arco et al.
2015; Fig. 5B).
Regarding the involvement of other α2δ subunits in the
pain pathway, the Drosophila melanogaster CACNA2D3
homologue, straitjacket, was identified as a gene involved
in pain processing (Neely et al. 2010).
PMCA
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Figure 5. Effect of α2δ-1 on cytosolic Ca2+ levels
A, overexpression of α2δ-1 in DRG neurons increased the width of
depolarization-induced intracellular calcium transients, measured
using Fura-2, induced by 100 Hz electrical stimulation (indicated by
the bar). Data are taken from a recent study (D’Arco et al. 2015). B,
cartoon of localization of CaV2.2 (N-type) calcium channels in the
plasma membrane near to ER and mitochondria. Ca2+ is taken up
into ER via the sarcoplasmic–endoplasmic reticulum Ca2+-ATPase
(SERCA) pump, and can be released by ryanodine receptor (RyR)
activation. Ca2+ is pumped out of cells by the plasma membrane
Ca2+-ATPase (PMCA). Cartoon adapted from from a recent study
(D’Arco et al. 2015).
Role of α2δ subunits in epilepsies
Prior to the identification of α2δ-1 as the receptor for
gabapentin (see below), this drug was known to be of use
in the treatment of some forms of epilepsy, as an adjunct
drug to improve seizure control (Marson et al. 2000).
Gabapentin binds to both α2δ-1 and α2δ-2, but not to
the other α2δ subunits. Subsequently, we found, together
with Michele Rees and Mark Gardiner, that the mutant
mouse strains ducky and ducky2J involved disruption of
the cacna2d2 gene (Barclay et al. 2001). Thesemice display
paroxysmal dyskinesia and absence seizures. Although the
mutations are different in the two mouse strains, being
a complex rearrangement of the gene in ducky and a
two base pair deletion in ducky2J, no full length α2δ-2
protein is produced in either strain (Barclay et al. 2001;
Brodbeck et al. 2002; Donato et al. 2006). Another mutant
mouse, entla,with a similar epileptic phenotype, was then
identified and found to have a duplication of exon 3 in
cacna2d2 (Brill et al. 2004). Mice with a targeted gene
deletion in cacna2d2 also show an epileptic and ataxic
phenotype (Ivanov et al. 2004). The mutation in ducky
and ducky2J mice is associated with abnormalmorphology
of the Purkinje cells (Brodbeck et al. 2002) and markedly
attenuated spontaneous activity in these neurons (Donato
et al. 2006).
Two human family pedigrees have recently been
investigated, in which homozygous recessive mutations in
CACNA2D2 resulted in infantile epileptic encephalopathy
(Edvardson et al. 2013; Pippucci et al. 2013). The carriers
of a single copy of the mutations had no phenotype,
in agreement with the absence of phenotype in mice
heterozygous for cacna2d2 expression (Barclay et al. 2001).
For α2δ-1, no central phenotypes have been identified
with any certainty in humans, possibly because most
neurons contain more than one subtype of α2δ sub-
unit, and these proteins may have a partially inter-
changeable function. However, CACNA2D1 has been
identified as a candidate gene associatedwith some cases of
West syndrome, an early-onset epileptic encephalopathy
(Hino-Fukuyo et al. 2015). The CACNA2D1 locus has
also been implicated in three patients investigated with
intellectual disability and epilepsy, although these patients
had deletions that also affected other genes (Vergult et al.
2015).
Night blindness
Mutations in the gene CACNA2D4, encoding α2δ-4,
produce photoreceptor dysfunction, resulting in a form
of night blindness (Wycisk et al. 2006b). A spontaneously
occurring mouse mutation has also been identified in
this gene, with a phenotype of autosomal recessive cone
dystrophy, again causing night blindness (Wycisk et al.
2006a,b). This emphasizes the importance of α2δ-4 in
photoreceptor function.
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Neuropsychiatric disorders
As we have reviewed recently (Heyes et al. 2015),
rare deleterious mutations in many of the calcium
channel genes including CACNA2D1, CACNA2D2 and
CACNA2D4 have been linked to both bipolar disorder
and schizophrenia (Purcell et al. 2014). Furthermore,
CACNA2D2 and CACNA2D4 have also been linked to
these psychiatric disorders in Genome-Wide Association
Studies (Cross-Disorder Group of the Psychiatric
GenomicsConsortium, 2013).However,most of the single
nucleotidepolymorphisms (SNPs) that are associatedwith
these disorders are in introns or intergenic regions, and
it remains unclear whether the SNPs have any effects to
increase or decrease overall expression, or expression of
particular splice variants, or otherwise alter the function
of the gene with which they are associated (Heyes et al.
2015). Nevertheless, it has recently been found that
expression of CACNA1S, CACNA2D4 and CACNA1F
were increased in hippocampal-like neurons derived from
induced pluripotent stem cells in patients with bipolar
disorder (Mertens et al. 2015). It is interesting that these
particular calcium channel genes normally show very
low expression in brain, so their physiological role in
hippocampus is unclear.
ACACNA2D3 splice site mutation was identified as one
of a large number of ‘likely gene-disrupting mutations’
involved in autism specrumdisorders (Iossifov et al. 2012).
Other rare germline mutations, introducing premature
stop codons or aberrant splicing, predicting truncated
proteins, have also been found to be associated with
autism (Girirajan et al. 2013; De Rubeis et al. 2014). Given
the likelihood that autism involves synaptic dysfunction
(Malhotra & Sebat, 2012; Ting et al. 2012), it is perhaps
not surprising that mutations in α2δ-3, which is present
in presynaptic terminals, are found to be one of many
potential genetic causes of autism.
Cardiac and endocrine dysfunction
The α2δ-1 protein is strongly expressed together with the
L-type calcium channels in skeletal, cardiac and smooth
muscle (Ellis et al. 1988; Jay et al. 1991; Klugbauer et al.
1999; Wolf et al. 2003; Walsh et al. 2009). CACNA2D1
mutations have been identified to cause human cardiac
dysfunction, including short QT syndrome (Templin et al.
2011) and Brugada syndrome (Burashnikov et al. 2010).
The mechanism of disruption resulting from mutations
in α2δ-1 has been probed (Bourdin et al. 2015). In
agreement with this, disruption of the cacna2d1 gene in
mice also caused a cardiac phenotype; the mice exhibited
a reduction in basal ventricular myocardial contractility,
associated with lower cardiac calcium current density
(Fuller-Bicer et al. 2009). Furthermore,mice lackingα2δ-1
also showed reduced pancreatic β-cell calcium currents,
andan increased tendency todevelopdiabetes, particularly
on one genetic background (Tuluc et al. 2014).
α2δ subunits as a therapeutic target
The α2δ subunits were discovered to be therapeutic targets
completely fortuitously, by virtue of being the unexpected
protein target for gabapentin binding. Otherwise they
would not have been considered a priori as a relevant
drug target, because of the absence of any known ligand
or mechanism of action.
Identification of α2δ subunits as gabapentin receptors
Gabapentin and pregabalin were first synthesized as
analogues ofGABA,with the aimof developing novel anti-
epileptic drugs (Taylor et al. 2007; Silverman, 2008). After
it was found that they did not act via GABA pathways,
purification of the brain 3H-gabapentin ‘receptor’ then
resulted in the surprise identification of α2δ-1 (Gee et al.
1996; Brown et al. 1998; Brown & Gee, 1998; Field et al.
2006; Li et al. 2011). 3H-Gabapentin also binds to α2δ-2
(Gong et al. 2001). Several residues in α2δ-1 and α2δ-2
are involved in the binding of the gabapentinoid drugs;
one important motif involves three arginine residues, just
proximal to the VWAdomain (Brown&Gee, 1998; Davies
et al. 2006; Field et al. 2006). The binding pocket for
gabapentin in α2δ-1 has been further elucidated in the
cryo-EM structure (Wu et al. 2015). One may speculate
that the basis of the binding of these drugs to α2δ-1 and
α2δ-2 subunits might stem from the presence of the Cache
domains, and their ancestral role to sense nutrients in
bacteria. Furthermore, it is likely that a low molecular
weight endogenous ligand might also bind to α2δ-1 and
α2δ-2, and be displaced competitively by gabapentin. The
binding affinity for 3H-gabapentin increases progressively
as the α2δ protein is purified or dialysed, or when iso-
lated in lipid raft fractions, suggesting that an endogenous
bound substance that competes with gabapentin binding
is being removed (Brown et al. 1998; Davies et al. 2006;
Lana et al. 2016). It is also possible that gabapentin binding
might disrupt the function(s) of the VWA domain or the
Cache domains (Dolphin, 2012; Cassidy et al. 2014). It
would be of great interest to determine the nature and
function of this endogenous small molecule.
Use of gabapentinoid drugs for epilepsy
Gabapentin is licensed for use as an adjunct drug in
several types of epilepsy (Marson et al. 2000) and as
a monotherapy in some partial-onset seizures (Glauser
et al. 2006). Pregabalin is also effective in the therapy
of some epilepsies (for review see Taylor et al. 2007). In
order to determinewhetherα2δ-1 orα2δ-2was responsible
for the anti-epileptic effects of these drugs, experiments
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were performed using knock-in mice, engineered to
contain a mutant α2δ-1 or α2δ-2 with reduced affinity
for gabapentinoid drug binding (Field et al. 2006; Lotarski
et al.2011).Pregabalinwasnot found tobe effective against
electroshock-induced seizures inmice inwhichα2δ-1 sub-
units aremutated, whereas it was still effective inmicewith
an equivalent mutation in α2δ-2 (Lotarski et al. 2014);
thus it is likely that the anti-seizure effect of these drugs is
primarily via binding to α2δ-1.
Neuropathic pain and the role of α2δ subunits
Gabapentin and pregabalin are licensed for use in the
treatment of various forms of neuropathic pain (Taylor
et al. 2007). In contrast, they have no effect on acute
nociceptivepain (Dickenson et al.2005;Moore et al.2009).
In neuropathic pain models in rodents, it has been shown
that binding of the gabapentinoid drugs to α2δ-1 sub-
units is required for their therapeutic effect (Field et al.
2006). This finding indicates that binding to α2δ-2 is
not important for the effect of gabapentin, and, indeed,
α2δ-2 was found to be reduced rather than up-regulated
in injured DRG neurons (Bauer et al. 2009). Pregabalin
is also used in the treatment of fibromyalgia, defined as
generalizedwidespreadpain,whichmay alsohave aneuro-
psychiatric aspect (Smith & Moore, 2012).
In a recent study, we have documented changes in
splicing, in addition to overall up-regulation of α2δ-1, in
injured rat DRG neurons (Lana et al. 2014). There was
elevated expression of a novel splice variant (α2δ-1 A
+ BC), which has a lower affinity for gabapentin (Lana
et al. 2014). It is interesting to speculate that variable
up-regulation of this, or other, splice variants in people
who develop neuropathic pain might be relevant to the
inconsistent efficacy of the α2δ ligand drugs within the
patient population.
Calcium channel currents: effects of gabapentinoid
drugs
Small acute inhibitory effects of gabapentin have been
observed on calcium currents in several systems (Stefani
et al. 1998; Martin et al. 2002; Sutton et al. 2002).
However, inother studiesnoacute responses togabapentin
have been reported on native or heterologously expressed
calcium channel currents (Schumacher et al. 1998; Davies
et al. 2006; Heblich et al. 2008; Hendrich et al. 2008). In
DRGs from α2δ-1-overexpressing mice, it was observed
that the calcium currents were rapidly inhibited by
gabapentin,whereas thiswasnot the case inwild-typemice
(Li et al. 2006). These results imply either that gabapentin
is not a direct channel blocker, whichwould indeed be pre-
dicted from the location of its binding site, or that α2δ-1
is not associated with all the relevant calcium channels in
DRGs from wild-type mice.
Calcium channel trafficking: effects of gabapentinoid
drugs
We have found that incubation of cultured cells for several
hours or days, rather than acute application of gabapentin,
produces a reduction of calcium currents, both in
expression systems when α2δ-1 or α2δ-2 was co-expressed,
and also in DRG neurons (Heblich et al. 2008; Hendrich
et al. 2008; Tran-Van-Minh & Dolphin, 2010). We
observed a corresponding reduction in expression of
the α2δ and associated α1 subunits on the cell surface
(Hendrich et al. 2008; Tran-Van-Minh & Dolphin, 2010;
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Figure 6. CaV2.2 cell surface expression: effect of gabapentin
Cell surface expression of bungarotoxin binding site (BBS) tagged CaV2.2 labelled with α-bungarotoxin (BTX)
coupled to AF488 dye (green). Left panel: examples of N2a cells transfected with CaV2.2/β1b/α2δ-1 in the
absence (left), and presence (right) of gabapentin (100 μM for 24 h). Right panel: mean (± SEM) data for cell
surface expression of CaV2.2, for cells expressing CaV2.2/β1b/α2δ-1 (black-filled and open bars), CaV2.2/β1b/α2δ-1
R241A (a mutant α2δ-1 that does not bind gabapentin; red-filled and open bars) in the absence (filled bars), and
presence (open bars) of gabapentin 100 μM for 24 h. Data are taken from a recent study (Cassidy et al. 2014).
The number of cells measured is indicated on the bars, ∗∗∗P<0.001, Student’s t test.
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Cassidy et al. 2014; Fig. 6). We also found that gabapentin
reduced forward trafficking of α2δ-2 by inhibiting a
post-Golgi trafficking step, in a process requiring Rab11,
which is involved in trafficking of cargoes in the recycling
endosome compartment (Tran-Van-Minh & Dolphin,
2010). When this pathway was isolated, a response to
gabapentin could be observed on a time-scale of 30 min.
Furthermore, we observed that chronic administration to
nerve-injured rats of an anti-hyperalgesic dosing regimen
of pregabalin reduced the elevation in the dorsal horn of
presynaptic α2δ-1. We interpreted this effect as being due
to reduced axonal trafficking in vivo (Bauer et al. 2009).
It is possible that gabapentinoid drugs selectively target
calcium channel populations that are rapidly turning over,
thus sparing skeletal muscle and cardiac channels, but this
will need further experimentation.
Binding of α2δ subunits to other proteins: effects
of gabapentinoid drugs
In various tissues it has been found that a proportion
of α2δ subunits can be purified by biochemical means
separately from α1 subunits (Gee et al. 1996; Mu¨ller et al.
2010), indicating that they may be only loosely associated
with α1 subunits, or may exist separately. This suggests
that they may have other functions in addition to being
calcium channel subunits. For example, theα2δ-3 proteins
have a documented role in formation of synaptic boutons
inDrosophila, which was found to be independent of their
involvement with calcium channels, in that it was not
mimicked by deletion of the relevant α1 subunit (Kurshan
et al. 2009). However, since α2δ subunits play a role in
trafficking calcium channels, as well as in calcium channel
function, it may be that α2δ subunits directly influence
the calcium transients which are involved in neurite
outgrowth and synapse formation during development
(Gu et al. 1994).
Furthermore, the α2δ-1 protein has been found
to co-immunoprecipitate with thrombospondins,
which are large multi-domain extracellular matrix
proteins (Eroglu et al. 2009); although it should be
noted that thrombospondins also bind to many other
proteins (Kazerounian et al. 2008). In the brain, specific
thrombospondins are produced by astrocytes and
promote the formation of silent excitatory synapses,
lacking postsynaptic receptors (Christopherson et al.
2005). Thrombospondin-induced synaptogenesis was
found to require the postsynaptic presence of α2δ-1
(Eroglu et al. 2009). Gabapentin was found to disrupt the
in vitro interaction between α2δ-1 and the synaptogenic
domain of thrombospondin-2, and also disrupted
synaptogenesis, although it had no effect on pre-formed
synapses (Eroglu et al. 2009). This effect on synaptogenesis
may not be relevant to the main mechanism of action
of gabapentin either in neuropathic pain or as an
antiepileptic drug, as much synaptic sprouting and
remodelling would have taken place before the onset of
therapy, although gabapentin could have a protective
effect via this mechanism. Nevertheless, it should be
emphasized that birth defects were found to be extremely
uncommon in babies following chronic gabapentin
exposure in the uterus of mothers who were taking the
drug as an anti-epileptic medication (Morrow et al. 2006;
Molgaard-Nielsen & Hviid, 2011), suggesting that it does
not have any significant effect on synapse formation
during development in utero.
As a corollary of a potential interaction between
α2δ-1 and thrombospondins, we have recently examined
whether interaction of thrombospondins with α2δ-1
might influence 3H-gabapentin binding (Lana et al. 2016).
We used thrombospondin-4 as it is upregulated in neuro-
pathic pain models (Pan et al. 2015). We found that in
membranes fromco-transfected cells, thrombospondin-4,
significantly reduced the affinity for 3H-gabapentin
binding to α2δ-1, in a divalent cation-dependent
manner. However, the effect on 3H-gabapentin binding
was not reproduced by the synaptogenic domain of
thrombospondin-4. Furthermore, we found only weak
co-immunoprecipitation of the two proteins, which could
not be reproduced with the synaptogenic domain of
thrombospondin-4 (Lana et al. 2016). We also could
not demonstrate any association between α2δ-1 and
thrombospondin-4 on the cell surface of transfected cells,
suggesting that the interaction between these two proteins
to disrupt 3H-gabapentin binding is occurring in an intra-
cellular compartment of the transfected cells (Lana et al.
2016). It is nevertheless possible that such an interaction
might reduce the efficacy of gabapentin in patients.
Conclusions and future directions
The α2δ subunits are important auxiliary subunits of the
CaV1 and CaV1 voltage-gated calcium channels. They
play major roles in trafficking of these channels, both to
the plasma membrane and to specific domains, as well
as influencing the activation and biophysical properties
of these channels. The mechanism of these effects, at
a cell biological level, still remains to be determined
in detail. They also play a role in the pathology of a
number of genetic and other diseases, and represent
an important therapeutic target site for drugs. Future
therapeutic directions are likely to include identifying
selective antagonists distinguishing CaV1.3 from CaV1.2
andotherL-type channels, finding selective antagonists for
the different T-type channels, and understanding better
the mechanism of action of the α2δ ligands.
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